NCT02614547Phase 2Completed

A Study to Evaluate SAGE-547 in Participants With Severe Postpartum Depression

Study sponsor: Supernus Pharmaceuticals, Inc. · SUPN

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2016-06-22Actual
Enrollment · participants21Actual
Source updated2025-09-15Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.